down arrow

Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
48.08
-2.53 (-5.0%)
BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 1.84 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

48.0848.08

52 Week

36.0088.70
Valuation
Technical
Day's Volume

CASH

1.84 k (452.68%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

66.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -2.54% CAGR growth in Net Sales over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.34
  • The company has been able to generate a Return on Equity (avg) of 4.40% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

With ROE of 5.2, it has a Expensive valuation with a 2.5 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 22 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.77

stock-summary
Return on Equity

5.24%

stock-summary
Price to Book

2.47

Revenue and Profits (1 Year):
Net Sales:
1 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-12.57%
0%
-12.57%
1 Year
7.61%
0%
7.61%
2 Years
19.01%
0%
19.01%
3 Years
74.52%
0%
74.52%
4 Years
493.58%
0%
493.58%
5 Years
464.98%
0%
464.98%

Colinz Labs for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.54%
EBIT Growth (5y)
4.40%
EBIT to Interest (avg)
0.34
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.82
Tax Ratio
29.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.92%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
2.47
EV to EBIT
15.90
EV to EBITDA
15.90
EV to Capital Employed
7.50
EV to Sales
2.37
PEG Ratio
11.10
Dividend Yield
NA
ROCE (Latest)
21.70%
ROE (Latest)
5.24%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Mani L S (34.45%)

Highest Public shareholder

Dipakbhai Haribhai Gaudani (1.31%)

Individual Investors Holdings

31.01%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -20.97% vs 6.29% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -68.75% vs 14.29% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.47",
          "val2": "1.86",
          "chgp": "-20.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.06",
          "val2": "0.17",
          "chgp": "-64.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.05",
          "val2": "0.16",
          "chgp": "-68.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.08%",
          "val2": "9.14%",
          "chgp": "-5.06%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -2.17% vs -1.60% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 20.83% vs 4.35% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.61",
          "val2": "3.69",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.33",
          "val2": "0.29",
          "chgp": "13.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.02",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.29",
          "val2": "0.24",
          "chgp": "20.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.14%",
          "val2": "7.86%",
          "chgp": "1.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -5.93% vs -0.55% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.86% vs 6.06% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.08",
          "val2": "5.40",
          "chgp": "-5.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.39",
          "val2": "0.42",
          "chgp": "-7.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.03",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.34",
          "val2": "0.35",
          "chgp": "-2.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.68%",
          "val2": "7.78%",
          "chgp": "-0.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -1.68% vs 2.58% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.52% vs 35.29% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.03",
          "val2": "7.15",
          "chgp": "-1.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.54",
          "val2": "0.61",
          "chgp": "-11.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.05",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.49",
          "val2": "0.46",
          "chgp": "6.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.68%",
          "val2": "8.53%",
          "chgp": "-0.85%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1.47
1.86
-20.97%
Operating Profit (PBDIT) excl Other Income
0.06
0.17
-64.71%
Interest
0.01
0.01
Exceptional Items
0.00
0.00
Standalone Net Profit
0.05
0.16
-68.75%
Operating Profit Margin (Excl OI)
4.08%
9.14%
-5.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -20.97% vs 6.29% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -68.75% vs 14.29% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3.61
3.69
-2.17%
Operating Profit (PBDIT) excl Other Income
0.33
0.29
13.79%
Interest
0.02
0.02
Exceptional Items
0.00
0.00
Standalone Net Profit
0.29
0.24
20.83%
Operating Profit Margin (Excl OI)
9.14%
7.86%
1.28%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -2.17% vs -1.60% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 20.83% vs 4.35% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5.08
5.40
-5.93%
Operating Profit (PBDIT) excl Other Income
0.39
0.42
-7.14%
Interest
0.03
0.03
Exceptional Items
0.00
0.00
Standalone Net Profit
0.34
0.35
-2.86%
Operating Profit Margin (Excl OI)
7.68%
7.78%
-0.10%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -5.93% vs -0.55% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -2.86% vs 6.06% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
7.03
7.15
-1.68%
Operating Profit (PBDIT) excl Other Income
0.54
0.61
-11.48%
Interest
0.04
0.05
-20.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.49
0.46
6.52%
Operating Profit Margin (Excl OI)
7.68%
8.53%
-0.85%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -1.68% vs 2.58% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 6.52% vs 35.29% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Colinz Laboratories Ltd stock-summary
stock-summary
Colinz Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995. The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc. The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Company Coordinates stock-summary
Company Details
A-101 Pratik Industrial Estate, Mulund Goregaon Link Road Mumbai Maharashtra : 400078
stock-summary
Tel: 91-022-25668002/8003
stock-summary
http://www.cindoc-cll.in
stock-summary
colinzlabs@yahoo.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."